Search results
What You Can Learn From Oak Street Health, Inc.'s (NYSE:OSH) P/S
Simply Wall St. via Yahoo Finance· 1 year agoWhen close to half the companies in the Healthcare industry in the United States have price-to-sales...
Stock To Watch: Could CVS’s Acquisition of Oak Street Health Boost Shareholder Revenue?
GOBankingRates via Yahoo Finance· 1 year agoCVS announced it acquired Oak Street Health in an all-cash $10.6 billion deal, following similar...
Oak Street Health, Inc. (OSH) Q2 2022 Earnings Call Transcript
Motley Fool· 2 years agoImage source: The Motley Fool. Oak Street Health, Inc. (NYSE: OSH)Q2 2022 Earnings CallAug 03, 2022,...
Oak Street Health Full Year 2022 Earnings: EPS Misses Expectations
Simply Wall St. via Yahoo Finance· 1 year agoOak Street Health (NYSE:OSH) Full Year 2022 Results Key Financial Results Revenue: US$2.16b (up 51%...
Stark County business roundup: Oak Street Health opens center in Canton
The Repository via Yahoo Finance· 8 months agoCANTON − Oak Street Health, which provides primary care for adults on Medicare, has opened its first...
Oak Street Health, Inc. (OSH) Reports Q3 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoOak Street Health, Inc. (OSH) delivered earnings and revenue surprises of 11.11% and 1%,...
Time to Buy CVS or Oak Street Health Stock on Potential Acquisition?
Zacks via Yahoo Finance· 1 year agoNews of CVS Health (CVS) potentially acquiring Oak Street Health (OHS) for $10 billion broke this...
CVS nearing $10.5 billion deal for primary-care provider Oak Street Health - WSJ
Reuters via Yahoo Finance· 1 year agoOak Street Health and CVS declined to comment on the report when contacted by Reuters. Bloomberg...
Why Shares of Oak Street Health Soared This Week
Motley Fool· 1 year agoShares of Oak Street Health (NYSE: OSH) were up 32.6% for the week, as of Thursday afternoon, according to data provided by S&P Global Market...
Here's Why You Should Retain CVS Health (CVS) Stock for Now
Zacks via Yahoo Finance· 4 months agoCVS Health Corporation CVS is well-poised for growth, backed by its consistently strong sales...